Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 20Gynecologic 14Gastrointestinal 8Head & Neck 4Genitourinary 4Thoracic 3Endocrine 3Dermatologic 3CNS 3Breast 3NET 2Other solid neoplasm 1Other 1

Conditions

Obesity 92Overweight 35Neoplasms 32Breast Neoplasms 23Sexual Dysfunction, Physiological 19Dyspnea 15Weight Loss 12Motor Activity 12Endometrial Neoplasms 11Polycystic Ovary Syndrome 10Mucositis 8Diabetes Mellitus, Type 2 8Diabetes Mellitus 8Obesity-Related Malignant Neoplasm 7Hypertension 7Depression 7Anxiety Disorders 7Pediatric Obesity 6Colorectal Neoplasms 6Uterine Cervical Neoplasms 5Sexual Dysfunctions, Psychological 5Obesity, Morbid 5Lung Neoplasms 5Leukemia 5Endometrial Hyperplasia 5Disease 5Constipation 5Sedentary Behavior 4Pulmonary Disease, Chronic Obstructive 4Prostatic Neoplasms 4

Interventions

atezolizumab 1TIC10 compound 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinosarcoma × Other × 1 year × Clear all
NCT05542407 2026-01-29

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 1 Recruiting
58 enrolled
GynecologicOtherSarcoma

Carcinosarcoma, Disease, Neoplasm Metastasis, Obesity, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡